As per the latest breaking news the Coronavirus vaccine trial is moving to phase III by Serum Institute Pune, hence there is an excitement among the citizens for the prices of the vaccine and the hottest talk in the market is about its prices as in the recent interview stated by Adar Poonawala, he has clearly mentioned the rate would be nearby 900-1000 Rupees
Do we really think that every Indian can afford 900 Rupees vaccines?
Now Serum Institute is planning to make 1 billion dozes for India and other countries. Basically the 1st and 2nd trials were tremendously successful and now with a little modification in the vaccine we are on the stage of mass production and these vaccines would be administered in 2 to 3 doses. The 1stdose would be the general and the second one would boost immunity.
Now talking about the target audience for the distribution of the vaccine should start with healthcare workers, frontline staff, children, and old people with weaker Immunity systems.
Well as per WHO, in its latest briefing praised the move but said that it is still unrealistic to have a vaccine deployed before early months of 2021, still we trust Serum Institute Pune with its great history and we hope to get the vaccine at the earliest.
Stay Tuned with us for the next Vaccine Update next week!